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Background: Patients with acute coronary syndrome (ACS) above the age of 80 are increasingly common, but underrepresented in clinical trials 
and might not always receive treatment according to guidelines recommendation.
methods: Patients above or below or equal to 80 years (n=13525) treated in Sweden 2011 in SWEDEHEART, a national registry in Sweden, were 
compared in terms of risk factors, in-hospital treatment, revascularization, and mortality.
results: The proportion of patients >80 years was 31% (n=6074) and 5% (n=1071) were >90 years. The elderly were more often women, had 
more often hypertension, previous myocardial infarction (MI), heart failure and stroke and accordingly on admission more often had treatment 
with beta-blockers, aspirin and ACE-inhibitors. Patients above compared to below 80 less often presented with ST-elevation MI /left bundle branch 
block (STEMI/LBBB) (25% vs 35%); reperfusion treatment was less common (60% vs 82%) and less often performed within recommended time 
frames (68% vs 73%). Elderly patients with non-ST elevation MI with high risk criteria above compared to <80 years underwent coronary angiography 
considerably less often (36% vs 85%) with a large variability between hospitals (9-92%). Revascularization with percutaneous coronary intervention 
occurred in 15%. Evidence based secondary preventive therapy was less used at discharge in the elderly, such as lipid lowering drugs (71% vs 96%), 
clopidogrel (78% vs 95%), ACE-inhibitors/ARB (74% vs 89%). In-hospital and 30-day mortality in those above compared to <80 was higher; 10% vs 
2.5% and 13% vs 3.5%, respectively. In patients >80, the in-hospital; 30-day and 1 year mortality has decreased considerably from 1995 to 2011 
from 21.7% to 9.8%; 25.9% to 13.2%, and 43.6% to 31.9%, respectively, which is a larger absolute reduction than in younger patients.
conclusions: Patients with ACS >80 years have a higher cardiovascular risk but receive less guideline recommended acute and long-term 
treatment despite similar improvements in outcomes over the years as younger patients. Undertreatment of elderly patients with ACS seems to be a 
remaining problem contributing to a high mortality.
